- Title: Subtitle
- Reply: Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline
- Creators
- Andres Duarte-Rojo - Northwestern UniversityBachir Taouli - Icahn School of Medicine at Mount SinaiDaniel H. Leung - Baylor College of MedicineDeborah Levine - Beth Israel Deaconess Medical CenterTarek Nayfeh - Mayo ClinicBashar Hasan - Mayo ClinicYahya Alsawaf - Mayo ClinicSamer Saadi - Mayo ClinicAbdul Mounaem Majzoub - Mayo ClinicApostolos Manolopoulos - Mayo ClinicSamir Haffar - Mayo ClinicAyca Dundar - Mayo ClinicM. Hassan Murad - Mayo ClinicDon C. Rockey - Medical University of South CarolinaMouaz Alsawas - Mayo ClinicRichard K. Sterling - Virginia Commonwealth University
- Resource Type
- Letter/Communication
- Publication Details
- Hepatology (Baltimore, Md.), Vol.81(2), pp.E30-E31
- DOI
- 10.1097/HEP.0000000000000952
- PMID
- 38836639
- NLM abbreviation
- Hepatology
- ISSN
- 0270-9139
- eISSN
- 1527-3350
- Publisher
- Lippincott Williams & Wilkins
- Number of pages
- 2
- Grant note
- AstraZeneca Pfizer Takeda; Takeda Pharmaceutical Company Ltd Durect Zydus Guerbert Intercept Cystic Fibrosis Foundation AbbVie Regeneron
- Language
- English
- Date published
- 02/01/2025
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985179233102771
Letter/Communication
Reply: Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline
Hepatology (Baltimore, Md.), Vol.81(2), pp.E30-E31
02/01/2025
DOI: 10.1097/HEP.0000000000000952
PMID: 38836639
Abstract
Details
Metrics
1 Record Views